Cetuximab plus FOLFOX for Patients with Metastatic Colorectal Cancer with Poor Performance Status and/or Severe Tumor-Related Complications

INTRODUCTION: Cetuximab-based chemotherapy showed a statistically significantly higher response rate compared with chemotherapy such as FOLFOX. Therefore, FOLFOX plus cetuximab is suspected to be the best regimen to alleviate tumor-related symptoms with a high response rate. CASE REPORT: Here we pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Shitara, Kohei, Yokota, Tomoya, Takahari, Daisuke, Shibata, Takashi, Sato, Yozo, Tajika, Masahiro, Ura, Takashi, Muro, Kei
Formato: Texto
Lenguaje:English
Publicado: S. Karger AG 2010
Materias:
Published: July 2010
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042020/
https://www.ncbi.nlm.nih.gov/pubmed/21347194
http://dx.doi.org/10.1159/000319474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042020/
https://www.ncbi.nlm.nih.gov/pubmed/21347194
http://dx.doi.org/10.1159/000319474

Ejemplares similares